Enter your mobile number below and we'll send you a link to download the free Kindle App. Then you can start reading Kindle books on your smartphone, tablet, or computer - no Kindle device required.
Getting the download link through email is temporarily not available. Please check back later.
To get the free app, enter your mobile phone number.
Get to Market Now! Turn FDA Compliance Into a Competitive Edge in the Era of Personalized Medicine Paperback – May 1, 2010
See the Best Books of the Month
Want to know our Editors' picks for the best books of the month? Browse Best Books of the Month, featuring our favorite new books in more than a dozen categories.
Customers Who Bought This Item Also Bought
Top Customer Reviews
The FDA regulates a vast variety of products including fruit juice, laser light shows, aspirin, and tooth brushes. The complexity of drugs can range from basic aspirin tables to multifaceted drug regimens that may require individual patient genetic information to determine which form is more appropriate. On the device side, this can range from the basic tongue depressor to highly advanced MRI machines that help determine brain functions.
The regulatory structure tends be "old school" with a classic command and control structure, while the new business reality means moving quickly to address business issues. The two approaches create a dichotomy, but, with deep insight, this book creates a meaningful and practical synthesis. For example, the book discuses FDA's approach for electronic records and electronic signatures (21 CFR Part 11). The regulations haven't changed in at least 12 years, but computing power and capability double every 24 months (by Moore's Law).
One of the most valuable, and interesting, aspects of the book is the recognition of the similarity among four sets of FDA regulations: Drug development and manufacture in GMP, Device development and manufacture in QSR, Laboratory practices GLP, and Clinical process in GCP. Most approaches focus on the differences among these approaches. This book recognizes the similarities and demonstrates how executives can take advantage of these similarities to create new and stronger approaches. This kind of thinking offers shorter time to market, a reduced development cost, and stronger regulatory compliance.Read more ›